Trial Profile
Effect of Losartan on Airway Mucociliary Dysfunction in Patients With COPD and Chronic Bronchitis
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Losartan (Primary)
- Indications Diabetic neuropathies; Heart failure; Hypertension
- Focus Pharmacodynamics; Proof of concept
- 01 Aug 2019 Status changed from recruiting to discontinued.
- 05 Feb 2018 Planned End Date changed from 1 May 2018 to 1 May 2019.
- 05 Feb 2018 Planned primary completion date changed from 1 Feb 2018 to 1 Feb 2019.